NEIL1 and melanoma: The interplay between RAS components and NEH1 activity in human melanoma was demonstrated by Olschewski et al. (133), where they identified that Ang II stimulates NEH1 activity and cell proliferation through the Ca+2/calmodulin signalling pathway, and that the effect was abolished by losartan – an AT1R blocker (133).